ENvue Medical, Inc.
NASDAQ Global MarketTotal Valuation
ENvue Medical, Inc. carries a market capitalization of 797,964.00, placing it among publicly traded companies globally. Its enterprise value stands at 50.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 797,964.00 |
| Enterprise Value | 50.87M |
Share Statistics
ENvue Medical, Inc. currently has 8.19M shares outstanding.
| Shares Outstanding | 8.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 11.02, and the price-to-book ratio stands at 1.65.
| PE Ratio | N/A |
| PS Ratio | 11.02 |
| PB Ratio | 1.65 |
| P/TBV Ratio | -22.15 |
| P/FCF Ratio | -1.84 |
| P/OCF Ratio | -1.82 |
Enterprise Valuation
| EV / Sales | 26.41 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
ENvue Medical, Inc. maintains a current ratio of 0.66, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.26, indicating elevated leverage, while an interest coverage ratio of -118.83 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.66 |
| Quick Ratio | 0.22 |
| Debt / Equity | 4.26 |
| Debt / EBITDA | -0.09 |
| Interest Coverage | -118.83 |
Financial Efficiency
| Return on Equity (ROE) | -68.80 |
| Return on Assets (ROA) | -46.87 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -23.29 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.01 |
Taxes
Over the trailing twelve months, ENvue Medical, Inc. has paid -353,000.00 in income taxes, reflecting an effective tax rate of 6.42.
| Income Tax | -353,000.00 |
| Effective Tax Rate | 6.42 |
Stock Price Statistics
ENvue Medical, Inc.'s stock has declined approximately -98.16986% over the past 52 weeks. The 50-day moving average sits at 4.00, while the 200-day moving average is 4.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -98.16986% |
| 50-Day Moving Average | 4.00 |
| 200-Day Moving Average | 4.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, ENvue Medical, Inc. generated 1.93M in revenue and converted that into -21.06M in net income, yielding earnings per share of -6.13. EBITDA reached -14.14M, while operating income came in at -15.09M.
| Revenue | 1.93M |
| Gross Profit | -502,000.00 |
| Operating Income | -15.09M |
| Pretax Income | -21.42M |
| Net Income | -21.06M |
| EBITDA | -14.14M |
| EBIT | -15.09M |
| Earnings Per Share (EPS) | -6.13 |
Balance Sheet
ENvue Medical, Inc. holds 1.08M in cash and equivalents against 1.31M in total debt, resulting in a net debt position of -4,000.00. Total book value stands at 30.76M, with working capital of -2.49M providing operational flexibility.
| Cash & Cash Equivalents | 1.08M |
| Total Debt | 1.31M |
| Net Debt | -4,000.00 |
| Equity (Book Value) | 30.76M |
| Book Value Per Share | 3.75 |
| Working Capital | -2.49M |
Cash Flow
ENvue Medical, Inc. produced -11.65M in operating cash flow over the past twelve months. After subtracting -95,000.00 in capital expenditures, free cash flow totaled -11.74M - equivalent to -3.42 per share.
| Operating Cash Flow | -11.65M |
| Capital Expenditures | -95,000.00 |
| Free Cash Flow | -11.74M |
| FCF Per Share | -3.42 |
Margins
ENvue Medical, Inc. operates with a gross margin of -26.06, reflecting its pricing power and cost economics. The operating margin of -783.59 and net profit margin of -1,093.61 provide insight into operational efficiency.
| Gross Margin | -26.06 |
| Operating Margin | -783.59 |
| Pretax Margin | -1,111.94 |
| Profit Margin | -1,093.61 |
| EBITDA Margin | -734.22 |
Dividends & Yields
The company's payout ratio of 14.04 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 14.04 |
| Shareholder Yield | -17.42 |
| FCF Yield | -54.43 |
Stock Splits
ENvue Medical, Inc.'s most recent stock split took place on September 1, 2026 with a 12:1 split ratio.
| Last Split Date | 9/1/2026 |
| Split Ratio | 12:1 |
Scores
ENvue Medical, Inc. posts an Altman Z-Score of -38.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -38.01 |